Format

Send to

Choose Destination
Genet Mol Res. 2017 Aug 17;16(3). doi: 10.4238/gmr16039742.

Synergic effect of oral contraceptives, GSTP1 polymorphisms, and high-risk HPV infection in development of cervical lesions.

Author information

1
Laboratório de Estudos Moleculares e Terapia Experimental, Departamento de Genética, , , Brasil.
2
Departamento de Engenharia e Meio Ambiente, Universidade Federal da Paraíba, Rio Tinto, PB, Brasil.
3
Unidade Acadêmica de Serra Talhada, Universidade Federal Rural de Pernambuco, Serra Talhada, PE, Brasil.
4
Laboratório de Variabilidade e Genética Humana, Departamento de Genética, , , Brasil.
5
Instituto de Saúde Materno-Infantil, IRCCS Burlo Garofolo, , Itália.
6
Laboratório de Pesquisa Molecular e Citológica, Departamento de Histologia, , , Brasil.
7
, , Itália.
8
Laboratório de Estudos Moleculares e Terapia Experimental, Departamento de Genética, , , Brasil acf_ufpe@yahoo.com.br.

Abstract

Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infected women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.

PMID:
28829907
DOI:
10.4238/gmr16039742
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center